In person and virtual
The TAP Life Sciences program by World Trade Centre Toronto empowers SMEs in the MedTech industry for strategic international growth. With top commercialization advisors, tailored coaching, and essential resources, it equips businesses to scale successfully.
This program, hosted in partnership with MaRS, is designed for leaders, CEOs, owners, and C-suite executives of Ontario-based MedTech companies. Over seven weeks, through a mix of virtual and in-person hands-on workshops and mentoring sessions, seasoned professionals help participants develop an effective commercialization strategy for international markets.
Canadian MedTech companies often secure their first clients internationally before establishing a significant presence in Canada. Early-stage ventures must quickly understand user, payer and regulatory preferences in global markets. Given the industry's rapid growth, international readiness is crucial for initial commercialization. Canadian companies must prioritize export readiness and international business skills early to succeed globally and build sustainable businesses.
Unlock Global Opportunities with TAP Life Sciences. This program is designed to equip SMEs in the Medical Technology industry with:
- Understanding key concepts in Medical Technology commercialization for international market access.
- Ensuring product meets healthcare needs and demonstrates value.
- Validating target markets and creating a tangible export plan to serve as a blueprint to support commercialization efforts.
- Creating profitable entities with a local and global customer base.
Contact:
Carissa Consoli
Senior Manager, Business Development
World Trade Centre Toronto
cconsoli@bot.com
The Trade Accelerator Program is supported by several partners, including Innovation, Science and Economic Development, in delivering Canada’s Export Diversification Strategy.
Agenda
Week 1: In-person // Tuesday, November 19 (9-5 pm)
- Mindsets and Blind Spots for Scaling Internationally
Week 2: Virtual
- Tuesday, November 26th: EU Market Access Fundamentals
- Friday, November 29th: US Market Access Fundamentals
Week 3: Virtual
- Monday, December 2nd: IP Protection and Commercialization of Medical Devices
- Friday, December 6: IP, Privacy, & Commercialization
Week 4: In-Person // Tuesday, December 10 (9-5 pm)
- Understanding the Nuts & Bolts
Week 5: Virtual // Monday, December 16
- Financial Strategies
Week 6: In-person // Tuesday, January 14
- Show me the money!
- Export Submission Plan
Week 7 - Virtual // January 2025 (Date TBC)
- Wrap up: One-on-one mentoring
Speakers
Tickets & Registration
Eligibility Criteria
- Life sciences companies post-seed with over $1 million in non-dilutive and equity financing.
- Have a differentiated and validated technology or product with market traction, including at least a minimum viable product and quantifiable evidence of maturity (revenue, number of users, investment, or TRL 6 or greater).
- Can demonstrate product-market fit by defining the target audience and the problem being solved.
- Have a passionate, strong, and committed management team with at least one senior manager (C-level or founder) who can commit to participating in the entire program, and a seasoned advisory board.
- Demonstrate readiness to talk with potential partners.
- Demonstrate financial resources to cover in-market costs.
- Registered as a business in Canada